Learn

The Medicinal Cannabis - Multiple Sclerosis, Spasticity, Tremor, and Dystoniacourse is divided into four comprehensive units, each focusing on different neurodegenerative conditions and the potential benefits of medicinal cannabis in their management. The course equips healthcare professionals with the knowledge to prescribe medicinal cannabis as part of a broader treatment plan, helping to improve patients' quality of life.

Unit 1: Multiple Sclerosis
This unit provides an introduction to multiple sclerosis (MS), detailing its symptoms, pathophysiology, and the role of medicinal cannabis in managing spasticity and pain. Participants will explore the effects of cannabinoids like THC and CBD on the endocannabinoid system and how these compounds can improve symptoms and overall quality of life for MS patients. The unit emphasizes that while medicinal cannabis is not a cure, it can offer significant symptom relief, particularly for spasticity​.

Unit 2: Parkinson’s Disease
In this unit, participants will learn about Parkinson’s disease, a progressive neurological condition affecting movement. The course highlights the evidence supporting the use of medicinal cannabis to manage motor symptoms such as tremor and rigidity, as well as non-motor symptoms like anxiety, pain, and sleep disturbances. The unit also covers dosing strategies and the importance of individualized treatment for Parkinson’s patients​.

Unit 3: Dystonia
Dystonia, a neurological movement disorder causing involuntary muscle contractions, is the focus of this unit. Participants will explore the use of medicinal cannabis in managing dystonia symptoms, particularly in cases where traditional treatments have failed. The unit discusses how cannabinoids can help reduce muscle spasms and improve the quality of life for dystonia patients, with practical case studies to illustrate effective treatment approaches​.

Unit 4: Summary and Practical Application
The final unit provides a summary of the course, reinforcing the key principles of medicinal cannabis treatment. It emphasises the need for individualised care, appropriate dosing, and ongoing patient monitoring. Participants are reminded that medicinal cannabis is not a one-size-fits-all solution, and treatment should focus on improving symptoms and quality of life. This unit also addresses practical considerations, such as state-specific regulations and the importance of patient-centred care​.

This course is ideal for healthcare professionals seeking to enhance their understanding of medicinal cannabis in treating complex neurological conditions, empowering them to offer an additional therapeutic option to patients struggling with chronic motor and non-motor symptoms.

Learning Outcomes

1. Manage multiple sclerosis and spasticity with medicinal cannabis
2. Manage tremor and dystonia with medicinal cannabis.

Details

Cost: $195

Suitable for: All degree qualified medical practitioners.

Study mode: 100% online

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 4 weeks to be reflected on your CPD Home Dashboard.